All Studies

Ashwagandha (Withania somnifera) and Shunthi (Zingiber officinale) in mild and moderate COVID-19: An open-label randomized controlled exploratory trial.

Ayurveda treatments used in India during COVID-19 showed positive outcomes in aiding early recovery from the virus.

Singh H et al (2023).
Complement Ther Med.
PubMed:
37482107

Anticancer activity of thymoquinone against breast cancer cells: Mechanisms of action and delivery approaches.

Nigella Sativa's compound, thymoquinone (TQ), has anti-cancer properties and can inhibit various tumorigenic processes. TQ can be encapsulated in nanocarriers to enhance its effectiveness against breast cancer. This study is important for scientists and clinical investigators.

Shabani H et al (2023).
Biomed Pharmacother.
PubMed:
37481931

Simultaneous estimation of five biomarkers of neuroprotective herb Ashwagandha NMITLI-118R AF1 in rat plasma and brain using LC-ESI-MS/MS: Application to its pharmacokinetic and stability studies.

Researchers developed and validated a method to measure biomarkers in a popular supplement. The method is sensitive, accurate, and efficient, providing valuable information for future studies and trials.

Dadge SD et al (2023).
J Chromatogr B Analyt Technol Biomed Life Sci.
PubMed:
37481788

Myco-synthesized copper oxide nanoparticles using harnessing metabolites of endophytic fungal strain Aspergillus terreus: an insight into antibacterial, anti-Candida, biocompatibility, anticancer, and antioxidant activities.

The researchers addressed the problem of antibiotic-resistant microbes caused by antibiotic overuse. They found that nanotechnology offers a solution by enabling the synthesis of new, multifunctional compounds to combat these microbes. This research is crucial for reducing global mortality rates.

Nassar AA et al (2023).
BMC Complement Med Ther.
PubMed:
37481531